Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daclatasvir/Sofosbuvir in Adolescents with HCV GT-4
NCT03540212Phase 3Unknown
- Sponsor
- Ain Shams University
- Start
- Dec 2017
- Primary completion
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of daclatasvir, sofosbuvir in hepatitis C virus infection, sponsored by Ain Shams University. Status: unknown.
02
Drugs
daclatasvirsofosbuvir
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on NCT03540212.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03540212.